These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9106222)
1. Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesias? Jeste DV; Kelsoe JR Mol Psychiatry; 1997 Mar; 2(2):86-8. PubMed ID: 9106222 [No Abstract] [Full Text] [Related]
5. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Segman R; Neeman T; Heresco-Levy U; Finkel B; Karagichev L; Schlafman M; Dorevitch A; Yakir A; Lerner A; Shelevoy A; Lerer B Mol Psychiatry; 1999 May; 4(3):247-53. PubMed ID: 10395214 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
7. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics. Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients. Zai CC; De Luca V; Hwang RW; Voineskos A; Müller DJ; Remington G; Kennedy JL Mol Psychiatry; 2007 Sep; 12(9):794-5. PubMed ID: 17767146 [No Abstract] [Full Text] [Related]
10. Interactive effect of cytochrome P450 17alpha-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia. Segman RH; Heresco-Levy U; Yakir A; Goltser T; Strous R; Greenberg DA; Lerer B Biol Psychiatry; 2002 Feb; 51(3):261-3. PubMed ID: 11839369 [TBL] [Abstract][Full Text] [Related]
11. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Gunes A; Scordo MG; Jaanson P; Dahl ML Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes. Ozdemir V; Basile VS; Masellis M; Kennedy JL J Biochem Biophys Methods; 2001 Jan; 47(1-2):151-7. PubMed ID: 11179771 [TBL] [Abstract][Full Text] [Related]
13. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179 [TBL] [Abstract][Full Text] [Related]
14. Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. Chen CH; Wei FC; Koong FJ; Hsiao KJ Biol Psychiatry; 1997 Apr; 41(7):827-9. PubMed ID: 9084902 [No Abstract] [Full Text] [Related]
15. Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. Lattuada E; Cavallaro R; Serretti A; Lorenzi C; Smeraldi E Int J Neuropsychopharmacol; 2004 Dec; 7(4):489-93. PubMed ID: 15383158 [TBL] [Abstract][Full Text] [Related]
16. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia. Zhang ZJ; Zhang XB; Hou G; Yao H; Reynolds GP Psychiatr Genet; 2003 Sep; 13(3):187-92. PubMed ID: 12960753 [TBL] [Abstract][Full Text] [Related]
17. The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia. Liou YJ; Lai IC; Liao DL; Chen JY; Lin CC; Lin CY; Chen CM; Bai YM; Chen TT; Wang YC Schizophr Res; 2006 Sep; 86(1-3):323-5. PubMed ID: 16769201 [No Abstract] [Full Text] [Related]
18. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Basile VS; Masellis M; Badri F; Paterson AD; Meltzer HY; Lieberman JA; Potkin SG; Macciardi F; Kennedy JL Neuropsychopharmacology; 1999 Jul; 21(1):17-27. PubMed ID: 10379516 [TBL] [Abstract][Full Text] [Related]
19. Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia. Mo GH; Lai IC; Wang YC; Chen JY; Lin CY; Chen TT; Chen ML; Liou YJ; Liao DL; Bai YM; Lin CC Schizophr Res; 2007 Dec; 97(1-3):302-4. PubMed ID: 17669630 [No Abstract] [Full Text] [Related]
20. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia. Ivanova SA; Al Hadithy AF; Brazovskaya N; Semke A; Wilffert B; Fedorenko O; Brouwers JR; Loonen AJ Hum Psychopharmacol; 2012 May; 27(3):334-7. PubMed ID: 22585593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]